| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/04/1991 | US5021234 Agent and product for the diagnosis and treatment of tumors and for the treatment of weaknesses of the cellular and humoral immune defense |
| 05/31/1991 | WO1991008213A1 Oligoribonucloside and oligodeoxyribonucleoside boranophosphates |
| 05/31/1991 | CA2069905A1 Oligoribonucleoside and oligodeoxyribonucleoside boranophosphates |
| 05/31/1991 | CA2030293A1 Isolation and structural elucidation of the cyclic peptide hymenistatin 1 |
| 05/30/1991 | WO1991007965A1 Mitonaphide infusion solution |
| 05/30/1991 | WO1991007509A1 Localization and characterization of the wilms's tumor gene |
| 05/30/1991 | WO1991007403A1 NOVEL BENZO [b] PHENANTHROLINE-1,7 DERIVATIVES, AND THEIR PREPARATION AND THERAPEUTICAL APPLICATIONS |
| 05/30/1991 | CA2059528A1 Mitonafide infusion solution |
| 05/29/1991 | EP0429209A1 New antibiotic chemical compound "DC 114-C" |
| 05/29/1991 | EP0429060A2 Benzothiazepines |
| 05/28/1991 | US5019596 Pharmaceutical compositions having therapeutical activity based on mercaptoethansulphonic acid |
| 05/28/1991 | US5019585 Tricyclic aromatase inhibitors |
| 05/25/1991 | WO1991007959A1 Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans |
| 05/23/1991 | CA2030212A1 Peptides |
| 05/23/1991 | CA2030160A1 Benzothiazepine metastasis treatment |
| 05/23/1991 | CA2030159A1 Anti-cancer drug potentiators |
| 05/23/1991 | CA2030158A1 Cancer treatments |
| 05/22/1991 | EP0428485A1 Novel antiidiotypic monoclonal antibodies |
| 05/22/1991 | EP0428376A1 Method for preparation of taxol using an oxazinone |
| 05/22/1991 | EP0428367A1 Isolation and structural elucidation of the cytostatic linear depsipetide dolastatin 14 |
| 05/22/1991 | EP0428188A2 Novel immunoconjugates and methods for their use in tumor therapy |
| 05/22/1991 | EP0428107A2 Use of quinolyl-and isoquinolyloxanole-2-ones for the production of a medicament for the treatment of multi-drug resistant tumors |
| 05/22/1991 | EP0428104A2 Treatment of multi-drug resistant tumors with pyridyloxazole-2-ones |
| 05/22/1991 | EP0427781A1 Ozonides of terpenes and their medical uses |
| 05/22/1991 | EP0427765A1 Alkoxy-4(1h)-pyridone derivatives, processes for preparing them and their use as drugs |
| 05/22/1991 | EP0427762A1 Substituted phenylacetonitriles used to overcome resistance to drugs in oncolytic therapy |
| 05/22/1991 | EP0427747A1 Substituted phenylacetonitriles used to overcome resistance to drugs in anti-malarial therapy. |
| 05/22/1991 | EP0237545B1 Production of pluripotent granulocyte colony-stimulating factor |
| 05/22/1991 | CN1051554A Indenoindole compounds ii |
| 05/22/1991 | CN1051503A Treatment of conditions and disease |
| 05/21/1991 | US5017599 Antitumor, antiviral distamycin A analog |
| 05/21/1991 | US5017579 Use of aminoalkoxyphenyl derivatives for reducing and/or controlling excessive intraocular pressure |
| 05/21/1991 | US5017371 Method for reducing side effects of cancer therapy |
| 05/21/1991 | CA2029748A1 Alkoxymethylidene epipodophyllotoxin glucosides |
| 05/16/1991 | WO1991006866A2 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 05/16/1991 | WO1991006658A2 Infective protein delivery system |
| 05/16/1991 | WO1991006629A1 Oligonucleotide analogs with novel linkages |
| 05/16/1991 | WO1991006548A1 Inhibitors of purine nucleoside phosphorylase |
| 05/16/1991 | WO1991006540A1 1,4-bis(alkylamino)-2,3-diaza-anthracene-9,10-diones |
| 05/16/1991 | WO1991006314A2 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
| 05/16/1991 | WO1991006307A1 Herbal treatment of malignancy |
| 05/16/1991 | DE3937607A1 Verwendung eines antikoagulanz zur behandlung von tumorerkrankungen Use of an anticoagulant in the treatment of tumor diseases |
| 05/15/1991 | EP0427633A1 Use of a polypeptide having an interferon gamma activity for the preparation of pharmaceutical compositions useful in the treatment of primitive pleural cancers |
| 05/15/1991 | EP0427190A2 Polyelectrolyte complexes for the treatment and the prophylaxis of viral diseases and process for their preparation |
| 05/15/1991 | EP0426666A1 Substituted quinazolinones as anticancer agents |
| 05/15/1991 | CN1051389A Novel antibodies reactive with human carcinomas |
| 05/15/1991 | CA2029714A1 Antiidiotypic monoclonal antibodies |
| 05/14/1991 | WO1991007182A1 rRNA SPECIFIC OLIGONUCLEOTIDES |
| 05/14/1991 | US5015578 BMY-41950 antitumor antibiotic |
| 05/14/1991 | US5015463 Porphyrins for fluorescent detection of tumor cells |
| 05/14/1991 | CA2068325A1 Rrna specific oligonucleotides |
| 05/14/1991 | CA2029715A1 Fluoro-naphthacenediones, their glycosilated derivatives and their manufacture procedures |
| 05/12/1991 | WO1991007187A1 Agent for neutralising the procoagulant activity associated with tumor cells |
| 05/12/1991 | CA2068312A1 Agent for neutralising the procoagulant activity associated with tumor cells |
| 05/11/1991 | CA2029670A1 Use of a polypeptide with gamma-interferon activity for the preparation of pharmaceutical compositions for the treatment of primitive cancers of the pleura |
| 05/08/1991 | EP0426653A1 4-demethoxy-4-amino-anthracyclines |
| 05/08/1991 | EP0426521A1 Use of interleukine 2 for the treatment of leukemias |
| 05/08/1991 | EP0426467A1 Prodrugs of 6-mercaptopurine and 6-thioguanine |
| 05/08/1991 | EP0426167A2 Antitumor substance, process for preparing the same, and pharmaceutical composition containing the same |
| 05/08/1991 | EP0425507A1 Compositions and methods for treating skin conditions and promoting wound healing. |
| 05/07/1991 | WO1991006563A1 Reduced irreversible bombesin antagonists |
| 05/07/1991 | US5013757 Physiologically active substance Tan-931, its derivatives, their production and use |
| 05/07/1991 | US5013738 L-glutamic acid derivatives |
| 05/07/1991 | US5013556 Lipids derivatized with polyoxyethylene glycol, drug delivery, antitumor agents |
| 05/07/1991 | CA2045494A1 Reduced irreversible bombesin antagonists |
| 05/07/1991 | CA2027601A1 Antitumor antibiotic bu-3983t |
| 05/07/1991 | CA1283917C Amino acid derivatives having anti-tumor activity and compositions containing them |
| 05/07/1991 | CA1283859C Penicillamine for treating immune damaging illnesses |
| 05/04/1991 | CA2331088A1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 05/03/1991 | WO1991006529A1 Glutamic and aspartic acid derivatives with antigastrin activity and a method for their preparation |
| 05/03/1991 | WO1991006322A1 Magnetocontrollable carrier with physiologically active substance and method for making said carrier |
| 05/03/1991 | CA2067569A1 Glutamic and aspartic acid derivatives with antigastrin activity and a method for their preparation |
| 05/03/1991 | CA2045504A1 Magnetically controlled carrier with physiologically active agent and process for preparing thereof |
| 05/02/1991 | WO1991005871A1 Bispecific heteroantibodies with dual effector functions |
| 05/02/1991 | WO1991005824A1 Anti-cancer compounds |
| 05/02/1991 | WO1991005795A1 Stem cell factor |
| 05/02/1991 | EP0425235A2 Cytotoxic agents comprising maytansinoids and their therapeutic use |
| 05/02/1991 | EP0424899A2 Novel anthracycline glycoside derivatives and preparing method thereof |
| 05/02/1991 | EP0424802A2 Tricyclic quinoline antineoplastic agents |
| 05/02/1991 | EP0424484A1 Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection. |
| 05/01/1991 | CN1012498B Process for n-(2'amino phenyl)-benzamide derivative and its drug composition |
| 04/30/1991 | US5011959 1,2-diaminocyclohexane-platinum complexes with antitumor activity |
| 04/30/1991 | US5011684 Administering monoclonal antibody to interleukin receptor |
| 04/30/1991 | US5011677 For radiation therapy |
| 04/30/1991 | CA1283750C Platinum co-ordination compounds |
| 04/30/1991 | CA1283656C Deoxyadenosine phosphate compounds and methods of making and using the same |
| 04/30/1991 | CA1283604C2 Dehydrated liposomes |
| 04/25/1991 | CA2067821A1 Infective drug delivery system using recombinant retroviral vectors |
| 04/24/1991 | WO1991005556A1 Camptothecin analogs as potent inhibitors of human colorectal cancer |
| 04/24/1991 | EP0424349A1 Synthesis of 1,4-dideoxy-1,4-imino-D-mannitol |
| 04/24/1991 | EP0424193A2 Use of actinonin for the manufacture of a medicament for angiogenesis inhibition |
| 04/24/1991 | EP0424107A1 A novel tumor-associated antigen |
| 04/24/1991 | EP0423980A1 Stem cell factor |
| 04/24/1991 | EP0423747A2 Glycosyl-etoposide prodrugs, process for their preparation and their use in combination with functionalised tumour-specific enzyme conjugates |
| 04/24/1991 | EP0423707A2 Platinum complexes |
| 04/24/1991 | EP0423649A1 Peptides and use thereof |
| 04/24/1991 | EP0423262A1 Protein fraction from the photosynthesis apparatus of plants for use as an active substance in the selective destruction of cancer cells and the post-treatment of scars, keloids and inflammatory processes and pharmaceutical products containing it. |
| 04/24/1991 | EP0423207A1 A migration stimulating factor |
| 04/24/1991 | EP0423193A1 A method of treating diseases caused by immunodeficiency states by administering human neutrophil chemotactic factor to human |
| 04/24/1991 | CN1050899A Novel entities for cancer therapy |